장애인용 기기 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the disability devices market size is expected to grow from USD 22.43 billion in 2025 to USD 23.69 billion in 2026 and is forecast to reach USD 31.14 billion by 2031 at a 5.62% CAGR over 2026-2031.

This report is Segmented by Device Type (Vision Aids, and More), End User (Home Care Settings, and More), Distribution Channel (Retail Pharmacies & DME Stores, E-Commerce Platforms, and Direct-To-Customer), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Disability Devices Market Trends and Insights

Increasing Prevalence of Age-Related Disabilities

Population aging is the strongest structural driver for the disability devices market. The World Health Organization projects that the global 60-plus cohort will reach 2.1 billion by 2050, with approximately 70% of adults over 70 experiencing clinically significant hearing loss. Japan's super-aged profile (29% of citizens already over 65) illustrates rising device intensity; roughly 1.2 million hearing aids were dispensed nationwide in 2025, nearly double the per-capita rate observed in the United States. Multiple comorbidities among older adults (stroke, osteoarthritis, diabetic neuropathy) are accelerating demand for multimodal platforms that combine fall detection, medication reminders, and emergency communication. Vendors capable of bundling such capabilities within a single interface are therefore best positioned to capture wallet share. Over the long term, demographic momentum ensures a stable baseline growth rate of at least 1.2 percentage points, contributing to the overall CAGR.

Favorable Government Reimbursement Policies for Assistive Technologies

Coverage expansion is widening access to premium devices. In the United States, Medicare processed more than USD 8 billion in Durable Medical Equipment, Prosthetics, Orthotics, and Supplies claims in 2025, and its 2024 rule change allowing over-the-counter hearing aids priced below USD 1,500 cut beneficiary out-of-pocket spending by roughly 40%. Germany's statutory insurers reimburse up to EUR 1,500 (USD 1,650) every six years for hearing aids, while France covers 60% of prosthetic costs up to EUR 2,500 (USD 2,750). Such reimbursement ceilings establish price bands and compel manufacturers to develop tiered product portfolios that align with payer thresholds. ISO 13485 certification increasingly serves as a gatekeeper for market entry, nudging small innovators toward strategic partnerships with established contract manufacturers.

High Upfront Cost of Advanced Assistive Devices

Premium aids remain expensive relative to household income in many regions. Microprocessor-controlled transfemoral limbs cost USD 50,000 to USD 100,000, while cochlear implant systems cost USD 30,000 to USD 50,000 before surgical fees. The World Health Organization estimates that 90% of people needing assistive technology lack access, primarily due to the high cost. Even in high-income markets, Medicare coinsurance requires beneficiaries to cover 20% of DMEPOS costs, translating to a range of USD 3,000-6,000 for a power wheelchair. This expense is driving a secondary market for refurbished devices, but liability concerns and lack of standard quality protocols continue to constrain supply.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid Advancements in Assistive Sensor and IoT Integration
2. Growing Adoption of 3D-Printed Personalized Prosthetics
3. Limited Insurance Coverage in Low- and Middle-Income Countries

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Communication Aids are expected to register a 7.54% CAGR from 2026 to 2031, reflecting the mainstreaming of augmentative and alternative communication platforms within classrooms and offices. The disability devices market size for Communication Aids is forecast to surpass USD 6 billion by 2031, as speech-generating devices integrate eye-tracking, natural language processing, and cloud-based vocabulary updates. Tobii Dynavox reported a 22% year-over-year increase in shipments in 2024, following its partnership with North American school districts. Mobility Aids, despite holding 34.34% of the disability devices market share in 2025, are transitioning from manual wheelchairs to sensor-rich power models that self-navigate narrow corridors and curb cuts. Permobil's M5 Corpus, launched late 2024, exemplifies the shift with LiDAR-based collision avoidance and GPS routing.

Demand for Hearing Aids remains buoyant as over-the-counter devices, priced at USD 200-1,500 per pair, widen access. Sonova's Sphere Infinio, the first hearing aid with an on-board AI speech-enhancement chip, delivers a 10-decibel improvement in background noise environments and extends battery life to 36 hours. Vision Aids are evolving from legacy magnifiers to AI-enabled wearables such as OrCam MyEye that translate text and identify faces. Daily living aids, dominated by adaptive utensils and bright pill dispensers, retain fragmentation but gain traction in aging-in-place scenarios, where Bluetooth medication reminders help lower hospital readmissions.

Complete Report Scope:

• By Device Type
  • Vision Aids
    • Braille Devices
    • Screen Readers & Magnifiers
    • Smart Glasses & Wearables
  • Hearing Aids
    • Behind-The-Ear
    • In-The-Ear
    • Bone-Anchored
  • Mobility Aids
    • Manual Wheelchairs
    • Power Wheelchairs
    • Mobility Scooters
    • Prosthetics & Orthotics
  • Communication Aids
  • Daily Living Aids
  • Other Device Types
• By End User
  • Home Care Settings
  • Hospitals
  • Ambulatory Care Centers
  • Rehabilitation Centers
  • Long-Term Care Facilities
  • Educational Institutions
  • Workplace Settings
• By Distribution Channel
  • Retail Pharmacies & DME Stores
  • E-Commerce Platforms
  • Direct-To-Customer (Company Owned)
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest Of Asia-Pacific
  • Middle East And Africa
    • GCC
    • South Africa
    • Rest Of Middle East And Africa
  • South America
    • Brazil
    • Argentina
    • Rest Of South America

Geography Analysis

North America contributed 43.54% of disability devices market revenue in 2025, underpinned by Medicare's USD 8 billion annual DMEPOS spend and the Department of Veterans Affairs' prosthetic benefits for 9 million veterans. High per-capita health expenditure, robust billing codes, and the FDA's expedited Technology Certification pathway speed time to market for breakthrough aids. Growth is moderating, however, as urban penetration plateaus and reimbursement models shift toward value-based contracting, which rewards functional outcomes instead of device volume.

The Asia-Pacific region is expected to record the fastest growth, with a 6.43% CAGR through 2031, as China, Japan, and India confront rapid demographic aging. China's population aged 60 and above reached 280 million in 2025 and is expected to surpass 400 million by 2035, prompting increased municipal procurement of ramps and tactile paving under the Barrier-Free Environment Construction Law. Japan subsidizes up to 90% of device costs for low-income seniors, making it the world's highest per-capita consumer of hearing aids. India reimburses up to 50% of aid costs for households below the poverty line, though caps limit access to advanced imports. Smart-device penetration is lower than in the West, but volume growth from cost-engineered manual aids offsets the mix.

Europe accounted for 28% of 2025 revenue. Reimbursement differs by nation; Germany offers EUR 1,500 per hearing aid every six years, while France covers 60% of prosthetic costs up to EUR 2,500. The Medical Device Regulation raises compliance costs yet improves traceability and post-market vigilance. The Middle East, Africa, and South America collectively accounted for approximately 10% of sales, largely due to low insurance penetration and fragmented supply chains. Brazil's Inclusion Law mandates workplace accommodations, but enforcement outside major cities remains patchy.

1. Advanced Bionics LLC
2. Cochlear
3. Demant
4. Drive DeVilbiss Healthcare
5. GF Health Products
6. GN Store Nord
7. Invacare
8. MED-EL
9. Merits Health Products
10. Meyra
11. Ottobock
12. Permobil AB
13. Pride Mobility Products
14. ReSound GN
15. Sivantos Inc. (Signia)
16. Sonova
17. Starkey Hearing Technologies
18. Sunrise Medical
19. Whisper
20. Widex A/S

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope Of The Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Prevalence of Age-Related Disabilities
  • 4.2.2 Favorable Government Reimbursement Policies for Assistive Technologies
  • 4.2.3 Rapid Advancements in Assistive Sensor and IoT Integration
  • 4.2.4 Growing Adoption of 3D-Printed Personalized Prosthetics
  • 4.2.5 Expansion of Universal Design Mandates in Emerging Economies
  • 4.2.6 Venture Capital Funding Surge in Neuro-Prosthetic Start-Ups
• 4.3 Market Restraints
  • 4.3.1 High Upfront Cost of Advanced Assistive Devices
  • 4.3.2 Limited Insurance Coverage in Low-And-Middle Income Countries
  • 4.3.3 Interoperability Gaps Between Legacy Aids and Smart Home Ecosystems
  • 4.3.4 Shortage of Trained Assistive Technology Specialists
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat Of New Entrants
  • 4.7.2 Bargaining Power Of Buyers / Consumers
  • 4.7.3 Bargaining Power Of Suppliers
  • 4.7.4 Threat Of Substitute Products
  • 4.7.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Device Type
  • 5.1.1 Vision Aids
    • 5.1.1.1 Braille Devices
    • 5.1.1.2 Screen Readers & Magnifiers
    • 5.1.1.3 Smart Glasses & Wearables
  • 5.1.2 Hearing Aids
    • 5.1.2.1 Behind-The-Ear
    • 5.1.2.2 In-The-Ear
    • 5.1.2.3 Bone-Anchored
  • 5.1.3 Mobility Aids
    • 5.1.3.1 Manual Wheelchairs
    • 5.1.3.2 Power Wheelchairs
    • 5.1.3.3 Mobility Scooters
    • 5.1.3.4 Prosthetics & Orthotics
  • 5.1.4 Communication Aids
  • 5.1.5 Daily Living Aids
  • 5.1.6 Other Device Types
• 5.2 By End User
  • 5.2.1 Home Care Settings
  • 5.2.2 Hospitals
  • 5.2.3 Ambulatory Care Centers
  • 5.2.4 Rehabilitation Centers
  • 5.2.5 Long-Term Care Facilities
  • 5.2.6 Educational Institutions
  • 5.2.7 Workplace Settings
• 5.3 By Distribution Channel
  • 5.3.1 Retail Pharmacies & DME Stores
  • 5.3.2 E-Commerce Platforms
  • 5.3.3 Direct-To-Customer (Company Owned)
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest Of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest Of Asia-Pacific
  • 5.4.4 Middle East And Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest Of Middle East And Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest Of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (Includes Global Level Overview, Market Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)
  • 6.4.1 Advanced Bionics LLC
  • 6.4.2 Cochlear Limited
  • 6.4.3 Demant A/S
  • 6.4.4 Drive DeVilbiss Healthcare
  • 6.4.5 GF Health Products Inc.
  • 6.4.6 GN Store Nord A/S
  • 6.4.7 Invacare Corporation
  • 6.4.8 MED-EL Medical Electronics
  • 6.4.9 Merits Health Products Co., Ltd.
  • 6.4.10 Meyra GmbH
  • 6.4.11 Ottobock SE & Co. KGaA
  • 6.4.12 Permobil AB
  • 6.4.13 Pride Mobility Products Corp.
  • 6.4.14 ReSound GN
  • 6.4.15 Sivantos Inc. (Signia)
  • 6.4.16 Sonova Holding AG
  • 6.4.17 Starkey Hearing Technologies
  • 6.4.18 Sunrise Medical LLC
  • 6.4.19 Whisper
  • 6.4.20 Widex A/S

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment